Althea THC18
Published 20 December 2021
Product
Althea THC18 Batch 210817 Expiry: Aug 2022 Product supplied via the TGA Special Access Scheme Althea THC18 is medicinal cannabis that can be used in the treatment of epilepsy, nausea, chronic pain and multiple sclerosis.
Why it was recalled
The level of tetrahydrocannabinol (THC) in this batch is too low and outside of the labelled concentration.
Hazard
If the level of tetrahydrocannabinol (THC) is too low, patients may receive a lower dose than prescribed and may find the product less effective, increasing the risk of serious health complications.
Source: Product Safety Australia. RecallMatch AU provides a screening summary and is independent of the ACCC.